THORP CLAY purchased 32.8% of their position (10K shares) of CLEARSIDE BIOMEDICAL, INC. on the open market
Open‑market purchase worth $8.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/25/2023ACC: 0001209191-23-050480
Director10% Owner
Since Dec 2018
+10K
Net shares
Net buyer
$8.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.86
Trade value
$8.60K
% of position
32.8%
9/25/2023
30.52K→40.52K
Total
Net shares
+10K
Net value
$8.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/25/2023 | P · Purchase | +10K | $0.86 | $8.60K | 32.8% | 30.52K | 40.52K |
| Total | +10K | $8.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.55M
Total
3.55M indirect3.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.55M | Indirect |
| Total | 3.55M | 3.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported